About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials | 4,268 Studies Recruiting

Clinical TrialsSchizophrenia

Schizophrenia Clinical Trials

Browse 4,268 clinical trials for schizophrenia. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 81-100 of 4,268 trials

CompletedA Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With SchizophreniaThis is a Phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group, 6-week trial to evaluate the efficacy, safety, and tolerability of 2 fixed doses of…NCT05227690·Little Rock, Arkansas and 24 others CompletedSafety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With SchizophreniaPrimary Objective: To evaluate the safety and tolerability of single doses of TV-44749 for subcutaneous (sc) use in Chinese participants with schizophrenia.NCT06253546·Beijing and 5 others

Related Searches

Data from ClinicalTrials.govTerms

CompletedCognitive Rehabilitation With Immersive Virtual Reality (IVR) in Schizophrenia: a Pilot Randomized Waiting List Controlled Feasibility StudyVirtual reality-based rehabilitation has recently gained increasing attention in the field of cognitive rehabilitation, allowing patients to engage in simulated real-life…NCT07427485·Torre del Greco, Naples

CompletedA Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307)This randomized, multi-center, double-blind, parallel-group, placebo-controlled study will evaluate the efficacy and safety of RO4917838 in patients with sub-optimally controlled…NCT01235520·Little Rock, Arkansas and 120 others

RecruitingReduction of Auditory-Verbal Hallucinations in Schizophrenia Through Cortical NeuromodulationApproximately 1% of the general population will be affected by schizophrenia over the course of their lives, with life expectancy being reduced by 20 years on average and quality…NCT06361160·Paris

CompletedFood Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With SchizophreniaTo investigate the effect of food on the pharmacokinetics of a single dose of brexpiprazole QW formulation.NCT06036108·Saga

CompletedCognitive and Emotional Factors in Visual Exploration Among Patients With SchizophreniaBackground: Patients with schizophrenia are abnormally disturbed by information onsets, which may result in a disadvantage in filtering relevant information.NCT02874482·Lille

RecruitingEfficiency Assessment of BREFORM. A Multicentric Stepped-wedge Randomized Control Trial.In psychiatry, caregiver burden is associated with excess physical and psychological morbidity in relatives of patients with schizophrenic disorders Single or multi-family…NCT05036590·Bron

CompletedStudy Comparing Bioavailability of Oral Formulations of VabicaserinThe purpose of this study is to determine the absorption rate of four oral formulations of vabicaserin.NCT00541996·Philadelphia, Pennsylvania

RecruitingDevelopment of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental IllnessThis research study aims to develop a brief group-based treatment called Resilience Training for Teens, then to test how well it protects high school students with mild symptoms…NCT05962879·Boston, Massachusetts

CompletedEfficacy of Selegiline in Negative Symptoms of SchizophreniaAntipsychotic drugs are effective in treating the positive symptoms of schizophrenia; however their efficacy in treating negative symptoms is limited.NCT00456976·Tabriz, East Azerbaijan Province

CompletedAuditory Verbal Hallucinations in SchizophreniaAuditory verbal hallucinations (AVHs) are speech perceptions in the absence of a relevant external stimulation.NCT01886417·Grenoble

CompletedMobile After-Care Support App: Pilot RCTThe overall aim of this program of research is to refine and test the feasibility and acceptability of a newly developed mobile device-delivered app, called Mobile After-Care…NCT03955250·Providence, Rhode Island

UnknownResting State Electroencephalogram for Psychotic DisordersElectroencephalography (EEG) has been proposed as a neurophysiological biomarker to delineate psychotic disorders.NCT05065489·Changsha, Hunan

TerminatedA Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their MedicationThe purpose of this study is to evaluate risperidone long-acting injection (an antipsychotic medication) versus oral antipsychotics in schizophrenia (psychiatric disorder with…NCT00256997·Dandenong and 43 others

CompletedA Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release CapsulesLyndra is developing an oral, extended release (ER) formulation of risperidone (LYN-005) presented in a capsule dosage form with the intent of reducing the frequency of dosing…NCT04567524·Long Beach, California and 4 others

UnknownTranscranial Magnetic Stimulation (TMS) in SchizophreniaUntil recently stimulation of nervous tissue deeper than approximately 2 cm from the scalp (will hence be called non-deep TMS) was not possible (3).A new coil ("H"-coil invented…NCT00564096·Beer Yaacov, Israel

CompletedA Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007)This 4-panel study will evaluate the safety, tolerability, pharmacokinetics (PK) and corrected QT interval (QTc) effect of MK-8189 versus placebo, as monotherapy in healthy…NCT03565068·Glendale, California

TerminatedClinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia1.NCT03593213·Bentonville, Arkansas and 96 others

CompletedrTMS as a Probe of Episodic Memory Neurocircuitry in SchizophreniaThis will be a single site pilot study.NCT04182113·Indianapolis, Indiana and 1 other

PreviousPage 5 of 214Next